Category: SGX Financial statements

SGX Financial statements

CGS SG ETF Series II (Fullgoal CSI 1000 ETF) 2025 Annual Report: Financials, Top Holdings & No Dividend Declared

Minichart

March 31, 2026

CGS SG ETF SERIES II (CGS Fullgoal CSI 1000 ETF): FY2025 Fin...

Continue Reading 0

SGX Financial statements

OUE Limited Announces Material Differences Between Audited and Unaudited FY2025 Financials; No Dividend Details Disclosed

Minichart

March 31, 2026

OUE Limited FY2025 Financial Review: Key Adjustments and Inv...

Continue Reading 0

SGX Financial statements

Manulife US REIT FY2025 Financial Update: Auditor’s Going Concern Emphasis, Figueroa Divestment, and No Dividend Details Announced

Minichart

March 31, 2026

Manulife US Real Estate Investment Trust (Manulife US REIT):...

Continue Reading 0

SGX Financial statements

Ever Glory United Holdings Limited: Key Differences Between Unaudited and Audited FY2025 Financial Statements & Earnings Update (No Dividend Details Provided)

Minichart

March 31, 2026

Ever Glory United Holdings Limited: FY2025 Audited Results A...

Continue Reading 0

SGX Financial statements

Astaka Holdings Limited Reports Material Variances Between Audited and Unaudited FY2025 Results; No Dividend Details Announced

Minichart

March 31, 2026

Astaka Holdings Limited: Analysis of FY2025 Audited Financia...

Continue Reading 0

SGX Financial statements

Reclaims Global Limited FY2026 Financial Results: 4.8% Revenue Growth & 1.0 Cent Dividend (Final and Special) Announced

Minichart

March 31, 2026

Reclaims Global Limited FY2026 Financial Results Analysis ...

Continue Reading 0

SGX Financial statements

Cordlife Group Limited 2025 Financial Audit: Disclaimer of Opinion, Regulatory Investigations, and No Declared Dividends

Minichart

March 31, 2026

Cordlife Group Limited FY2025 Financial Review: Auditor Disc...

Continue Reading 0

SGX Financial statements

CSOP Investments III VCC Annual Report 2025: Fund Performance, Top Holdings, and Dividend Details

Minichart

March 31, 2026

CSOP Investments III VCC Annual Performance Review (FY2025) ...

Continue Reading 0

SGX Financial statements

Thakral Corporation Ltd 2025 Financial Results: Record S$174M Profit, Segment Performance, and Dividend Details (S$0.065 per share)

Minichart

March 30, 2026

Thakral Corporation Ltd FY2025 Financial Analysis: Record Ea...

Continue Reading 0

SGX Financial statements

Tianjin Pharmaceutical Da Ren Tang Group 2025 Financial Results: Revenue Drops, Gross Margin Surges, and RMB 1.28 Per Share Final Dividend Proposed

Minichart

March 30, 2026

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited...

Continue Reading 0